Multidrug-resistance protein 1 in focal cortical dysplasia

Lancet

Volumn 357, Issue 9249, 2001, Pages 42-43

  Sisodiya, S M ^a   Lin, W R ^a   Squier, M V ^b   Thom, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; SYNAPSIN I; UNCLASSIFIED DRUG;

ARTICLE; BRAIN BLOOD VESSEL; BRAIN CELL; CONTROLLED STUDY; CORTICAL DYSPLASIA; EPILEPSY; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035814649     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03573-X     Document Type: Article

References (5)

1. Over-expression of P-glycoprotein in malformations of cortical development
2. Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP)
3. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal fluid drug-permeability barrier
4. Abnormal cortical development and epilepsy
5. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP